CRK Courses
CRK Courses
Youtube Facebook Linkedin

Call Agent

0720999920

Send Email

[email protected]

0
Your Cart
No products in the cart.
Course Content
Module 1: Understanding the Pharmacovigilance System in Kenya
This module provides a comprehensive overview of the pharmacovigilance system in Kenya, highlighting its significance in ensuring patient safety and the regulatory framework governing it. It is divided into three key lessons that cover different aspects of pharmacovigilance:Lesson 1: Introduction to Pharmacovigilance and Its Importance in Patient Safety In this introductory lesson, learners gain a fundamental understanding of pharmacovigilance and its vital role in safeguarding patient health and well-being. It explores the concept of adverse drug reactions (ADRs) and emphasizes the need for systematic monitoring and reporting to identify and mitigate potential risks associated with pharmaceutical products.Lesson 2: Pharmacovigilance Regulations and Reporting Requirements in Kenya This lesson delves into the specific regulatory landscape of pharmacovigilance in Kenya. It outlines the legal framework and reporting obligations that pharmaceutical companies, healthcare professionals, and other stakeholders must adhere to. Topics covered include regulatory agencies, timelines for reporting, and non-compliance consequences.Lesson 3: Methods of Adverse Drug Reaction (ADR) Reporting The final lesson explores the various methods and channels for reporting adverse drug reactions in Kenya. It provides insights into the different reporting mechanisms, including spontaneous reporting by healthcare professionals and patients, as well as the role of pharmacovigilance centers and online reporting portals. Learners will understand the importance of accurate and timely reporting in building a robust pharmacovigilance system.In summary, Module 1 offers a holistic understanding of the pharmacovigilance system in Kenya, starting with its fundamental principles and expanding into the regulatory framework and practical reporting mechanisms. This knowledge equips learners with the necessary tools to enhance drug safety and patient care in the country.
0/8
Module 1 pre-test
Module 1 Overview
00:00
Lesson 1: Introduction to Pharmacovigilance and Its Importance in Patient Safety
08:39
Lesson 2: Pharmacovigilance Regulations and Reporting Requirements in Kenya
06:35
Role-play : ADR Reporting Interaction at a Healthcare Facility
03:03
Lesson 3: The process of reporting pharmacovigilance in Kenya
15:46
Group discussions on the barriers to ADR reporting and strategies to overcome them
Module 1 Assessment Test
Module 2: Identifying and Reporting ADRs in Specific Medical Areas
Welcome to Module 2 of our Medical Education Program on Adverse Drug Reaction (ADR) Reporting. This module will explore ADR reporting in specific medical areas and understand the importance of early detection and intervention to ensure patient safety. Let's get started with Lesson 1: ADR Reporting in Oncology. Lesson 1: ADR Reporting in Oncology: Case Studies and Best Practices This lesson will focus on ADR reporting in oncology, where patients undergo cancer treatment with various medications. We will examine real-life case studies highlighting the significance of ADR reporting in early detection and intervention. Additionally, we will discuss best practices for accurate and efficient ADR reporting in oncology. Lesson 2: ADR Reporting for Vaccines: Ensuring Vaccine Safety in Kenya Lesson 2 will revolve around ADR reporting for vaccines, an essential aspect of ensuring vaccine safety in Kenya. Vaccines play a critical role in preventing infectious diseases, and ADR reporting is vital to monitor and address any potential adverse effects associated with vaccination. Lesson 3: ADR Reporting for Anti-hypertensive Medications: Managing Cardiovascular Risks In Lesson 3, we will focus on ADR reporting for anti-hypertensive medications. Hypertension, or high blood pressure, is a prevalent condition, and proper ADR reporting is crucial in managing cardiovascular risks and optimizing treatment outcomes. Lesson 4: ADR Reporting for Neglected Non-communicable Diseases Medications Lesson 4 will explore ADR reporting for neglected non-communicable diseases (NCDs) medications. These medical conditions have historically received limited attention, making ADR reporting even more critical in improving patient care and safety. Case Studies: Identifying ADRs in Oncology and Reporting Correctly In these case studies, we will explore scenarios where healthcare providers must identify ADRs in oncology patients accurately and report them correctly. Through interactive activities, we will enhance our understanding of the challenges and importance of ADR reporting in oncology. Case Study: Identifying and Reporting ADRs in Vaccines and Anti-hypertensive Medications In this case study, we will face scenarios related to vaccine administration and anti-hypertensive medication use. By actively participating in this case study, we will practice recognizing ADRs and reporting them appropriately to ensure patient safety. Lesson 5: Identifying and reporting adverse events in endemic communicable diseases in Kenya (TB, HIV/AIDS, and malaria): case studies and hands-on training on properly completing adverse event reports for neglected endemic communicable disease medications. Learning Objectives: 1. Understand the significance of adverse drug reaction (ADR) reporting in specific medical areas, recognizing its role in improving patient safety and treatment outcomes. 2. Identify common adverse drug reactions associated with medications used in specific medical areas, such as cardiology, neurology, and infectious diseases. 3. Recognize the challenges and complexities of ADR reporting in specialized medical fields, including polypharmacy, overlapping symptoms, and patient variability. 4. Implement best practices for ADR reporting in specific medical areas, including timely reporting, utilizing common terminology and grading scales, and collaborating with multidisciplinary teams. 5. Utilize technology and data collection methods to streamline ADR reporting processes in specialized medical fields and contribute to pharmacovigilance efforts. 6. Comprehend the ethical considerations in ADR reporting, including patient confidentiality, informed consent, and reporting of uncertain causality or rare events. 7. Foster a culture of reporting in specific medical areas, overcoming barriers to reporting and encouraging healthcare professionals' engagement and patient involvement. Interactive Activities: 1. Case Studies and Discussion: Participants will be presented with real-life case studies of adverse drug reactions in specific medical areas, such as cardiology, neurology, and infectious diseases. They will discuss the implications of these ADRs on patient health and treatment decisions and brainstorm possible reporting strategies and interventions. 2. Interactive Quizzes: Throughout the module, interactive quizzes will be conducted to reinforce participants' understanding of ADR reporting in specific medical areas. These quizzes will cover topics such as best practices, terminology, and technology utilization. 3. Role-Playing animation videos: to simulate ADR reporting scenarios in specialized medical fields. They will practice communication with patients about potential ADRs and report to pharmacovigilance centers. 4. Technology Demonstration: A demonstration of technology tools and software used for ADR reporting in specific medical areas will be provided. Participants will learn how to use these tools to streamline reporting processes and improve data collection. By incorporating these interactive activities into the module, participants can apply their knowledge, engage in discussions, and develop practical skills related to ADR reporting in specialized medical fields. These activities will enhance participants' understanding of the importance of ADR reporting, equip them with effective reporting strategies, and foster a culture of vigilant pharmacovigilance in specific medical areas. Throughout this module, we encourage active engagement and discussion. Let's work together to improve our knowledge and skills in ADR reporting for specific medical areas, ultimately enhancing patient care and promoting safer healthcare practices. Let's embark on this learning journey together!
0/14
Module 2 Pre-test
Introduction
00:00
Lesson 1: ADR Reporting in Oncology: Case Studies and Best Practices
16:53
Roleplay: ADR Reporting in Oncology
03:26
Role-play quiz
Lesson 2: ADR Reporting for Vaccines: Ensuring Vaccine Safety in Kenya
09:59
Roleplay: ADR Reporting for Vaccines: Ensuring Vaccine Safety in Kenya
04:05
Lesson 3: ADR Reporting for Anti-hypertensive Medications: Managing Cardiovascular Risks
14:58
Roleplay: ADR Reporting for Anti-hypertensive Medications
03:23
Lesson 4: ADR Reporting for Neglected Non-communicable Diseases Medications
19:23
Roleplay Scenario: ADR Reporting for N-NCDs Medications in Kenya
03:35
Case Study Quiz: ADR Reporting for Neglected Non-communicable Diseases Medications in Kenya
Lesson 5: Identifying and Reporting Adverse Events in Endemic Communicable Diseases in Kenya (TB, HIV/AIDS, and Malaria):
09:54
Roleplay: Identifying and Reporting Adverse Events in Endemic Communicable Diseases in Kenya
03:49
Module 3: Strategies for Managing and Preventing ADRs
• Lesson 1: Understanding Adverse Drug Reactions and Their Management • Lesson 2: Preventing ADRs: Strategies for Safer Medication Use • Lesson 3: Implementing Risk Minimization Measures • Assignment: Develop a Risk Minimization Plan for a Specific Medication
0/6
Module 3 Pre-test
Module Overview
00:00
Lesson 1: Understanding Adverse Drug Reactions and Their Management
10:14
Lesson 2: Preventing ADRs – Strategies for Safer Medication Use
05:06
Group discussion: Preventing ADRs: Strategies for Safer Medication Use:
Module 3 Assessment test
Module 4: Effective Communication with Patients on ADR Reporting
• Lesson 1: Importance of Patient Communication in ADR Reporting • Lesson 2: Communicating ADRs to Patients and Their Families: Best Practices • Quiz: Assessing Communication Skills in ADR Reporting
0/7
Module 4 Pre-test
Module 4 Overview
01:22
Lesson 1: Importance of Patient Communication in ADR Reporting
11:53
Lesson1 Roleplay
03:57
Lesson 2: Designing a Communication Strategy for Communicating Adverse Drug Reactions (ADRs) to Patients and Their Families
06:15
Lesson 3: Communicating ADRs to Patients and Their Families: Best Practices
12:09
Lesson 3 Roleplay
02:23
Module 5: Reporting ADRs in Pediatric Populations
0/7
Module 5 Pre-test
Module 5 Overview
00:00
Lesson 1: Special Considerations for ADR Reporting in Pediatric Patients
08:03
Lesson 2: Case Studies: Identifying and Reporting ADRs in Children Outline:
08:28
Discussion: Challenges and Lessons Learned in Pediatric ADR Reporting
Roleplay: Pediatric ADR Reporting: Empowering Parents and Healthcare Providers
03:45
Module 5 Assessment test
Module 6: Building Pharmacovigilance Systems in Resource-Limited Settings
0/5
Module 6 Pre-test
Module 6 Overview
00:00
Lesson 1: Challenges and Opportunities in Pharmacovigilance Implementation in Kenya
05:34
Lesson 2: Strategies for Effective Pharmacovigilance in Resource-Limited Settings
04:57
A dialogue between two healthcare workers, Sarah and James, who are discussing the challenges and opportunities of building pharmacovigilance systems in resource-limited settings like Kenya, as well as strategies for effective implementation
04:58
Pharmacovigilance
    About Lesson

    Module 5: Reporting ADRs in Pediatric Populations

    Lesson 1: Special Considerations for ADR Reporting in Pediatric Patients:

    Outline:

    1.1 Introduction to ADR Reporting in Pediatric Populations

    1.2 Importance of Pediatric ADR Reporting for Drug Safety

    1.3 Challenges in Recognizing and Reporting ADRs in Children

    1.4 Strategies for Enhancing Pediatric ADR Reporting

    1.5 Collaboration with Parents and Caregivers in ADR Reporting

    Learning Objectives: By the end of this lesson, participants will be able to:

    1. Understand the unique considerations and challenges in reporting Adverse Drug Reactions (ADRs) in pediatric populations.
    2. Recognize the significance of pediatric ADR reporting in promoting drug safety and ensuring the well-being of children.
    3. Identify common challenges in recognizing and reporting ADRs in children, including underreporting and limited awareness.
    4. Implement strategies to enhance pediatric ADR reporting, such as educational initiatives and the use of patient-friendly reporting systems.
    5. Appreciate the critical role of parents and caregivers in pediatric ADR reporting and the importance of collaborative communication.

    Lesson 2: Case Studies: Identifying and Reporting ADRs in Children

    Outline:

    2.1 Case Study 1: Allergic Reaction to Antibiotics in a Toddler

    2.2 Case Study 2: Neurological ADRs in an Adolescent Taking Antiepileptic Drugs

    2.3 Case Study 3: Gastrointestinal ADRs in a School-Age Child on Chronic Medication

    2.4 Case Study 4: Dermatological ADRs in an Infant Receiving Vaccinations

    2.5 Case Study 5: ADRs Associated with Over-the-Counter Medications in a Pre-teen

    2.6 Discussion: Challenges and Lessons Learned in Pediatric ADR Reporting

    Learning Objectives: By the end of this lesson, participants will be able to:

    1. Analyze and identify Adverse Drug Reactions (ADRs) in pediatric patients through real-life case studies.
    2. Understand the importance of comprehensive ADR reporting to assess the safety and efficacy of medications in children.
    3. Apply knowledge of ADR recognition and reporting to different age groups, considering developmental variations.
    4. Discuss challenges and potential solutions for pediatric ADR reporting, considering age-appropriate communication approaches.
    Previous
    Next
    0% Complete